DANBURY, Conn., Jan. 6, 2011 /PRNewswire/ -- Biodel Inc. today announced that Dr. Errol De Souza, President and CEO of Biodel, will present a corporate update at the 29th Annual JPMorgan Healthcare Conference on Thursday, January 13, 2011 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time). The update will include information about the development of new follow-on formulations of its lead product, Linjeta(TM), including milestones and timelines.
The JPMorgan Healthcare Conference will be held January 9-13, 2011, at the Westin St. Francis Hotel in San Francisco, California.
Interested parties may access the presentation in the investor relations section of Biodel's website at http://www.biodel.com/ which will link to a live webcast to be archived for 14 days.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. For further information regarding Biodel, please visit the company's website at http://www.biodel.com/.
BIOD-G CONTACT: Seth Lewis, +1-646-378-2952 News Provided by Acquire Media
Biodel Inc.
CONTACT: Seth Lewis, +1-646-378-2952
Web Site: http://www.biodel.com/
